Select Page
Neuronicon

Neuronicon

Neuronicon Technology sold to the pharmaceutical group Lundbeck. Through research, Neuronicon has produced new knowledge that in the long term can lead to new types of medicine that can curb serious brain diseases, for example Alzheimer’s, and disabling brain...
ActionPharma

ActionPharma

Has sold a drug candidate to a major pharmaceutical company for DKK 623 million. Action Pharma has developed a drug to prevent acute kidney failure in cardiac surgery. The company originated from research at Aarhus University led by professor of biomedicine Søren...
Synact Pharma

Synact Pharma

  Listed on Spotlight Stock Market in Sweden. www.synactpharma.com FollowFollow Synact Pharma is working on the development of new drugs to treat inflammatory disorders such as rheumatoid arthritis. The company was founded in 2012 by Professor Søren Nielsen and...
MediConnect

MediConnect

MediConnect Shortens month-long waiting lists across the country. MediConnect has developed a new network-based supply system for the electronic dissemination of specialist medical examinations. The company was founded in 2001 by a married couple from Aarhus. CAPNOVA...
ProteoPharma

ProteoPharma

ProteoPharma   Protein idea sold to Swiss pharmaceutical giant Roche. ProteoPharma has developed a protein that can remove deposited cholesterol from the blood vessels and can potentially evolve into a new super drug that can act as a sort of ‘drainage’ in...